Finally, the ERK1-2 proteins, which represent the downstream components of the NRAS-BRAF-MEK signaling kinase cascade, have been found to be activated through phosphorilation (pERK1-2) in melanoma and implicated in rapid malignant cell growth, mostly as a consequence of mutations in upstream components of the pathway [25-27]. This evidence concerns the gene NRAS and melanoma.